Detection of novel gyrA mutations in nalidixic acid-resistant isolates of Salmonella enterica from patients with diarrhoea

International Journal of Antimicrobial Agents

Volumn 37, Issue 4, 2011, Pages 360-364

  Hamidian, Mohammad ^a,d   Tajbakhsh, Mercedeh ^a   Tohidpour, Abolghasem ^a   Rahbar, Mohammad ^b   Zali, Mohammad Reza ^a   Walther Rasmussen, Jan ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Iranian Reference Health Laboratory   (Iran)

^c University of Copenhagen   (Denmark)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

gyrA gene mutations; Nalidixic acid resistance; Salmonella spp.

Indexed keywords

ALANINE; ARGININE; ASPARTIC ACID; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; ENROFLOXACIN; GLUTAMIC ACID; GLYCINE; LEUCINE; LEVOFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; PROLINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE; THREONINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DIARRHEA; DISK DIFFUSION; GENE AMPLIFICATION; GENE MUTATION; IRAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SALMONELLA ENTERICA; SEQUENCE ANALYSIS;

DIARRHEA; DNA GYRASE; DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; NALIDIXIC ACID; POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA;

EID: 79952816096     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.12.013     Document Type: Article

References (15)

1. Fàbrega A, Madurga S, Giralt E, Vila J. Mechanism of action of and resistance to quinolones. Microb Biotechnol 2009;2:40-61.
2. Yoshida H, Bogaki M, Nakamura M, Nakamura S. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother 1990;34:1271-2. (Pubitemid 20177394)
3. Friedman SM, Lu T, Drlica K. Mutation in the DNA gyrase A gene of Escherichia coli that expands the quinolone resistance-determining region. Antimicrob Agents Chemother 2001;45:2378-80. (Pubitemid 32664483)
4. Vashist J, Vishvanath, Kapoor R, Kapil A, Yennamalli R, Subbarao N, et al. Interaction of nalidixic acid and ciprofloxacin with wild type and mutated quinolone-resistance-determining region of DNA gyrase A. Indian J Biochem Biophys 2009;46:147-53.
5. Madurga S, Sánchez-Céspedes J, Belda I, Vila J, Giralt E. Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance. Chembiochem 2008;9:2081-6.
6. Popoff MY, Bockemühl J, Gheesling LL. Supplement 2002 (no. 46) to the Kauffmann-White scheme. Res Microbiol 2004;155:568-70.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. Document M100-S16. Wayne, PA: CLSI; 2006.
8. Hamidian M, Tajbakhsh M, Walther-Rasmussen J, Zali MR. Emergence of extended-spectrum β-lactamases in clinical isolates of Salmonella enterica in Tehran, Iran. Jpn J Infect Dis 2009;62:368-71.
9. White DG, Piddock LJ, Maurer JJ, Zhao S, Ricci V, Thayer SG. Characterization of fluoroquinolone resistance among veterinary isolates of avian Escherichia coli. Antimicrob Agents Chemother 2000;44:2897-9.
10. Griggs DJ, Gensberg K, Piddock LJ. Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals. Antimicrob Agents Chemother 1996;40:1009-13. (Pubitemid 26115239)
11. Hopkins KL, Davies RH, Threlfall EJ. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 2005;25:358-73. (Pubitemid 40558766)
12. Lee K, Lee M, Lim J, Jung J, Park Y, Lee Y. Contamination of chicken meat with Salmonella enterica serovar Haardt with nalidixic acid resistance and reduced fluoroquinolone susceptibility. J Microbiol Biotechnol 2008;18:1853-7.
13. Walther-Rasmussen J, Høiby N. Salmonella enterica serovar Typhi and S. Paratyphi A: need to expand the QRDR region? Epidemiol Infect 2010 [Epub head of print], doi:10.1017/S0950268810002487.
14. Renuka K, Kapil A, Kabra SK, Wig N, Das BK, Prasad VV, et al. Reduced susceptibility to ciprofloxacin and gyrA gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A. Microb Drug Resist 2004;10:146-53. (Pubitemid 38879015)
15. Preisler A, Heisig P. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G). J Antimicrob Chemother 2009;63:290-4.